19.05.2014 13:20:46

Compugen Q1 Loss Narrows - Quick Facts

(RTTNews) - Compugen Ltd. (CGEN) said that its net loss for the first quarter of 2014 narrowed to $1.9 million or $0.04 per share, from last year's $3.4 million or $0.09 per share, resulting from an increase in revenues recognized for the quarter, partially off-set by the increased corporate activities primarily relating to research and development.

Revenues for the first quarter were $2.1 million, compared with $162,000 for the comparable period in 2013. Revenues for the latest-quarter consisted primarily of the portions of the non-refundable upfront payment received under the August 2013 collaboration and license agreement with Bayer Pharma AG, that were recognizable during the quarter in accordance with US GAAP revenue recognition accounting.

Analysen zu Compugen Ltd.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Compugen Ltd. 1,53 2,00% Compugen Ltd.